Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Medical Care
Cannabis leadership clinical scrutiny is essential as corporate messaging often outpaces evidence-based medicine. Tilray Brands' 4/20 announcement highlights the importance of evaluating medical cannabis claims critically. Clinicians must focus on…
4/20 and the Future of Cannabis Medicine: Botanical Therapies and Clinical Challenges
Botanical cannabis medicine challenges are central to advancing evidence-based cannabis therapeutics. This article discusses the tension between whole-plant therapies and pharmaceutical standardization. Clinicians must navigate these challenges to…
Cal Poly Humboldt Receives $3 Million for Cannabis Professorship
Cal Poly Humboldt received $3 million to establish an academic cannabis professorship funding dedicated to advancing cannabis research. This endowment supports rigorous studies and education in cannabis science. The funding aims to accelerate…
Medical Cannabis Methods Evolving in the Bluegrass – WBKO
Kentucky medical cannabis program updates highlight evolving delivery methods and clinical protocols. These changes impact physician education and patient access statewide. Understanding these updates is essential for clinicians and patients alike.
GDF: Dablicator | Alpine Fizz | Strain-Specific Cannabis Oil | 1g | NOLA – Kenner
The GDF Dablicator Alpine Fizz strain specific cannabis oil is a 1g product marketed in NOLA Kenner. This product listing highlights its clinical relevance and safety considerations. However, it lacks peer-reviewed evidence for clinical use.
Catching Our Eye News Roundup, April 3, 2026 – Ohio Capital Journal
This roundup highlights notable clinical interest emerging findings in cannabis medicine. It emphasizes evidence-based practice and clinical standards for healthcare providers. Stay informed on key cannabis policy developments worth monitoring closely.
Top 15 Companies in Global Cannabidiol (CBD) Consumer Health Market Size
The global cannabidiol consumer health market is rapidly evolving with key companies driving product quality and clinical reliability. Understanding market leaders helps clinicians recommend consistent CBD products. This article highlights the top 15…
Canopy Growth’s Apollo Clinics Named Top Medical Cannabis Provider by Toronto Star Readers
Apollo Clinics received medical cannabis provider recognition from Toronto Star readers, reflecting growing patient satisfaction. This award highlights the importance of quality cannabis healthcare services. However, clinical outcomes and protocols…
‘Should never have been prescribed’: private UK cannabis clinics face call for tighter regulation
Private UK cannabis clinics regulation is under scrutiny due to concerns about prescribing standards and patient safety. This focus on regulation aims to improve clinical oversight and establish clear guidelines. Enhanced private UK cannabis clinics…
Federal Policy Allows States to Self-Regulate Cannabis: New Report Insights
State cannabis regulatory variation creates significant challenges for clinical care. Differences in testing and potency standards impact patient safety and treatment continuity. Understanding these variations is essential for effective medical cannabis…
